On November 5, 2026, OneCareAI took part in the Barcelona Deep Tech Summit, one of the most relevant gatherings of the European deep tech ecosystem. The event brought together startups, corporations and key innovation actors to explore emerging technologies, discover impactful solutions and forge new connections.
At the summit, the team showcased how the OneCareAI platform combines ECG data from wearable devices with molecular and genetic biomarkers, processed through AI models trained on the Barcelona Supercomputing Center's High Performance Computing infrastructure, to detect silent atrial fibrillation - the leading preventable cause of cardioembolic stroke - before it causes irreversible damage.
Prior to the event, OneCareAI had been selected as a finalist for the BSC Connects Tech for Impact Awards 2026, in the framework of Projecte Aina - the Catalan initiative promoting AI solutions with real impact on people's health and quality of life. The selection as finalist placed OneCareAI among the most promising deep tech startups at the summit.
At the end of the day, OneCareAI was awarded the second prize at the BSC Connects Tech for Impact Awards 2026. The recognition highlights the platform's potential to transform early disease diagnosis through the combined power of AI and High Performance Computing.
This new partnership represents a significant milestone: working alongside a global pharmaceutical leader like AstraZeneca and the Catalan AI initiative Projecte Aina opens new opportunities to validate and scale the platform's capabilities across a broader range of disease indications, beyond stroke prevention.
This recognition reinforces OneCareAI's position as one of the most promising deep tech startups in the European health AI space, and validates the scientific approach pioneered by the Innostroke research project at the Barcelona Supercomputing Center - the foundation on which OneCareAI was built.
AstraZeneca
Projecte Aina
BSC · CNS